New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...

Switzerland launches a major AI project to advance precision oncology and bring artificial intelligence into cancer diagnosis and treatment.

Med Center Health has been named a Center of Excellence (COE) by GO2 for Lung Cancer (GO2). An estimated 237,000 Americans ...

Next-generation sequencing (NGS) has transformed how clinicians approach biomarker testing in solid tumors, according to ...

Hereditary breast cancer due to genetic mutations accounts for 5% to 10% of breast cancers. Breast cancer is the most ...

Research in non-small cell lung cancer (NSCLC) has made considerable strides in recent years, particularly in the context of ...

Groundbreaking research shows that as men age, harmful genetic mutations in sperm become more common—not just from random ...

EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...

The FDA approved taletrectinib (Ibtrozi)-- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell ...

Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy with back-to-back review articles published in ...